Skip to the main content

Review article

THROMBOEMBOLIC COMPLICATIONS IN ONCOLOGIC PATIENTS

Doroteja Pavan Jukić
Suzana Lide Škalec
Ante Ćorušić
Goran Vujić
Željko Štajcer


Full text: croatian pdf 103 Kb

page 20-23

downloads: 4.706

cite


Abstract

Deep venous thrombosis is the second most common cause of death in cancer patients. Patients with cancer are at heightened risk of venous and arterial thromboembolism due to the hypercoagulable state. Surgery, chemotherapy, radiotherapy and immobilization of the cancer patients heighten this risk even more. Having in mind all the pre- and intraoperative prognostic factors, we are capable to prevent and reduce possible complications. Low-molecular-weight heparin is proven to be beneficial in the prevention and treatment of the thrombotic complications. There are numerous studies reporting on improved survival of cancer patients treated with LMW heparin.

Keywords

venous thromboembolism; malignant disease; low-molecular-weight heparin

Hrčak ID:

15572

URI

https://hrcak.srce.hr/15572

Publication date:

1.3.2004.

Article data in other languages: croatian

Visits: 6.425 *